Archives 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 April 01, 2019 Update on Nucant cancer programme Read More March 14, 2019 IMM March 2019 Corporate Update Read More December 17, 2018 Appointment of NOMAD Read More September 07, 2018 IMM September 2018 Corporate Update Read More January 25, 2017 Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More January 24, 2017 Change of Adviser Read More December 22, 2016 Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More November 09, 2016 Notification of Major Interest by Legal & General Read More October 26, 2016 TR1 Notification of Major Interest Read More October 21, 2016 Proposed Accelerated Bookbuild for Vendor Placing and Issue of Equity Read More October 21, 2016 Close of Accelerated Bookbuild Read More September 30, 2016 INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2016 Read More 123…7
January 25, 2017 Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More
December 22, 2016 Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More
